Diagnostic and treatment workup for IgG4-related disease

References

• Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41(7):613–625.
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–551.
   PubMed Web of Science ®Google Scholar
• Culver EL, Sadler R, Simpson D, et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016;111(5):733–743.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688–1699.
   PubMed Web of Science ®Google Scholar
• Uchida K, Masamune A, Shimosegawa T, et al. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. 2012;2012:358371.
   PubMedGoogle Scholar
• Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466–2475.
   PubMed Web of Science ®Google Scholar
• Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–1819.
   PubMed Web of Science ®Google Scholar
• Karim F, Loeffen J, Bramer W, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14(1):18.
   PubMed Web of Science ®Google Scholar
• Sato Y, Yoshino T. IgG4-related lymphadenopathy. Int J Rheumatol. 2012;2012:572539.
   PubMedGoogle Scholar
• Cheuk W, Yuen HK, Chu SY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(5):671–681.
   PubMed Web of Science ®Google Scholar
• Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014;69(2):269–272.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Yasuoka H, Yamaoka K, et al. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther. 2016;18:167.
   PubMed Web of Science ®Google Scholar
• Ohno K, Sato Y, Ohshima K-I, et al. A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep. 2015;5:13539.
   PubMed Web of Science ®Google Scholar
• Stone JH. IgG4-related disease: pathophysiologic insights drive emerging treatment approaches. Clin Exp Rheumatol. 2016;34(4 Suppl 98):66–68.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181(2):191–206.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yamashita K, Kudo M. IgG4-related disease and innate immunity. Curr Top Microbiol Immunol. 2017;401:115–128.
   PubMed Web of Science ®Google Scholar
• Beltrame RC, Friderichs M, Fior BR, et al. Acute tubulointerstitial nephritis with severe renal impairment associated with multisystem IgG4-related disease. J Bras Nefrol. 2016;38(3):374–378.
   PubMedGoogle Scholar
• Bennett AE, Fenske NA, Rodriguez-Waitkus P, et al. IgG4-related skin disease may have distinct systemic manifestations: a systematic review. Int J Dermatol. 2016;55(11):1184–1195.
   PubMed Web of Science ®Google Scholar
• Babur Güler G, Cantürk E, Güler E, et al. IgG4-related aortitis mimicking intramural hematoma. Anatol J Cardiol. 2016;16(9):728–729.
   PubMed Web of Science ®Google Scholar
• Abe A, Manabe T, Takizawa N, et al. IgG4-related sclerosing mesenteritis causing bowel obstruction: a case report. Surg Case Rep. 2016;2(1):120.
   PubMed Web of Science ®Google Scholar
• Acevedo Ribo M, Ahijado Hormigos FJ, Diaz F, et al. IgG4-related disease and idiopathic membranous nephropathy: “The clothes do not make the man”. Clin Nephrol. 2016;86(12):345–348.
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30.
   PubMed Web of Science ®Google Scholar
• Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–358.
   PubMed Web of Science ®Google Scholar
• Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615–626.
   PubMed Web of Science ®Google Scholar
• Xu W-L, Ling Y-C, Wang Z-K, et al. Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis. Sci Rep. 2016;6:32035.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14–18.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014;59(5):1954–1963.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58(11):1504–1507.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016;55(6):1000–1008.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Cheryk LA, Carruthers MN, et al. Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66(1):213–217.
   PubMed Web of Science ®Google Scholar
• Egner W, Swallow K, Lock RJ, et al. Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease. Clin Exp Immunol. 2016;186(1):57–63.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–195.
   PubMed Web of Science ®Google Scholar
• Doorenspleet ME, Hubers LM, Culver EL, et al. Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology. 2016;64(2):501–507.
   PubMed Web of Science ®Google Scholar
• Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013;57(6):2390–2398.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: baseline clinical and laboratory features in 125 patients with biopsy-proven disease. Arthritis Rheumatol. 2015;67(9):2466–2475.
   PubMed Web of Science ®Google Scholar
• Kawa S. The Immunobiology of Immunoglobulin G4 and complement activation pathways in IgG4-related disease. Curr Top Microbiol Immunol. 2017;401:61–73.
   Google Scholar
• Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32(1):16–21.
   PubMed Web of Science ®Google Scholar
• van de Stadt LA, de Vrieze H, Derksen NIL, et al. Antibodies to IgG4 Hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation. Arthritis Rheumatol. 2014;66(5):1133–1140.
   PubMed Web of Science ®Google Scholar
• Kiyama K, Yoshifuji H, Kandou T, et al. Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. BMC Musculoskelet Disord. 2015;16:129.
   PubMed Web of Science ®Google Scholar
• Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with (18)F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014;41(8):1624–1634.
   PubMed Web of Science ®Google Scholar
• Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261(2):625–633.
   PubMed Web of Science ®Google Scholar
• Chuang TL, Hsu BB, Chi CL, et al. Gallium SPECT/CT in evaluation of IgG4-related disease: a case report and literature review. Medicine (Baltimore). 2016;95(37):e4865.
   PubMed Web of Science ®Google Scholar
• Ishii S, Shishido F, Miyajima M, et al. Whole-body Gallium-67 scintigraphic findings in IgG4-related disease. Clin Nucl Med. 2011;36(7):542–545.
   PubMed Web of Science ®Google Scholar
• Aoki A, Sato K, Itabashi M, et al. A case of Mikulicz’s disease complicated with severe interstitial nephritis associated with IgG4. Clin Exp Nephrol. 2009;13(4):367.
   PubMed Web of Science ®Google Scholar
• Ghably JG, Borthwick T, O’Neil TJ, et al. IgG4-related disease: a primer on diagnosis and management. Ann Allergy Asthma Immunol. 2015;114(6):447–454.
   PubMed Web of Science ®Google Scholar
• Bateman AC, Culver EL. IgG4-related disease-experience of 100 consecutive cases from a specialist centre. Histopathology. 2017;70(5):798–813.
   Google Scholar
• Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.
   PubMedGoogle Scholar
• Brito-Zeron P, Kostov B, Bosch X, et al. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016;95(26):e4002.
   PubMed Web of Science ®Google Scholar
• Sah RP, Chari ST. Recent developments in steroid-responsive pancreatitides (autoimmune pancreatitis). Curr Opin Gastroenterol. 2015;31(5):387–394.
   PubMed Web of Science ®Google Scholar
• Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607–1615.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62(6):1755–1762.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Awakawa T, Takahashi H. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years. Ann Rheum Dis. 2015;74(8):e46.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171–1177.
   PubMed Web of Science ®Google Scholar
• Khan ML, Colby TV, Viggiano RW, et al. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk. 2010;10(3):217–219.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Takano K, et al. Efficacy of abatacept for IgG4-related disease over 8 months. Ann Rheum Dis. 2016;75(8):1576–1578.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Takano K, et al. Response to: ‘Could abatacept directly target expanded plasmablasts in IgG4-related disease?’ By Alegria et al. Ann Rheum Dis. 2016;75(11):e74.
   PubMed Web of Science ®Google Scholar
• Davis PM, Nadler SG, Stetsko DK, et al. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction. Clin Immunol. 2008;126(1):38–47.
   PubMed Web of Science ®Google Scholar
• Balaskas K, De Leval L, La Corte R, et al. Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment. Ocul Immunol Inflamm. 2012;20(6):478–480.
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Yen S-H, Tsai -C-C, et al. Adjunctive orbital radiotherapy for ocular adnexal IgG4-related disease: preliminary experience in patients refractory or intolerant to corticosteroid therapy. Ocul Immunol Inflamm. 2015;23(2):162–167.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Ho H, Sauer B, et al. Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc. 2009;70(2):303–309.
   PubMed Web of Science ®Google Scholar
• Maeta S, Munemura C, Ishida C, et al. [Case report; acute renal failure due to IgG4-related retroperitoneal fibrosis]. Nihon Naika Gakkai Zasshi. 2012;101(4):1079–1081.
   PubMedGoogle Scholar
• Hart PA, Moyer AM, Yi ES, et al. IgG4–related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4–related disease. Human Pathology. 2012;43(11):2084–2087.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):67–71.
   PubMed Web of Science ®Google Scholar
• Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014;109(10):1675–1683.
   PubMed Web of Science ®Google Scholar
• Asano J, Watanabe T, Oguchi T, et al. Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol. 2015;42(11):2135–2142.
   PubMed Web of Science ®Google Scholar